Home › Trial NCT05232552
Study of Anlotinib With Chemoradiation for Patients With Locally Advanced Nasopharyngeal Carcinoma
- Trial IDNCT05232552
- StatusUnknown
- PhasePhase 2
- Study typeInterventional
- SponsorZhejiang Cancer Hospital
- Enrollment37
- Start date2021-01-01
- ConditionsNasopharyngeal Carcinoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.